Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Our RESILIENCE team has prepared this video in which we explain how the therapy is randomized for the RESILIENCE clinical trial.
For this procedure, we will use the electronic case report form (e-CRF), a software that will assign one of the corresponding therapies randomly.
The research team will access to the e-CRF via the website through the username and the password given by the sponsor.
